There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Inhaled interleukin-2 (IL-2) is an effective and safe treatment in metastasing renal
cell carcinoma (mRCC) but known to potentially elicit respiratory symptoms.